Molecular map of liver disease could transform how MASLD is diagnosed and monitored
A new study establishes a molecular map of disease progression in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD), and identifies a set of blood biomarkers that could improve diagnosis.
2026
research-highlights